Ceribell Inc
CBLLHealthcare·Medical Devices·USA·Small·NASD·Nov 13 • 7:20 AM ET
26.47+0.12 (0.47%)
2026-11-13 13:47 CET
Market cap
$1.03B
Revenue, TTM
108.72 USD m
Net income, TTM
-73.88 USD m
Free cash flow, TTM
-56.43 USD m
EPS diluted, TTM
-1.95
Price
CBLL against its 20, 50 and 200-day averagesPatternshover a marker to name it
8.4% under the 52-week high of 28.89 on 3 Nov 2026. 52-week low 12.36 on 13 Nov 2025. Last 15 sessions, 32.2% high to low
Volume 0.00× normal · the line is the 50-bar volume average
Setup. RS line 60
CANSLIM 4 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%)
VCP 6 of 6
Minervini 4 of 4
Zanger 1 of 5 — fails: RSI (14): Not Oversold (>50); Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 4 of 5 — fails: Average Volume: Over 500K
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 0 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 25
Value 0 of 4 — fails: P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1) — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 3 of 4 — fails: Average Volume: Over 500K
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 2 of 3 — fails: Average Volume: Over 500K
Profile
CBLL52-week range, 85% of the way up
12.3628.89
Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.
| Index | RUT |
|---|---|
| Employees | 327 |
| IPO | Oct 11, 2024 |
| Beta | 0.86 |
| ATR, 14d | 1.46 |
| Rel volume | 0.00 |
| Short float | 7.56% |
| Insider own | 33.38% |
| Inst own | 66.34% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $1.03B |
| Enterprise Value | 932.30M |
| Income | -73.88M |
| Sales | 108.72M |
| Book / share | 3.03 |
| Cash / share | 3.02 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 327 |
| IPO | Oct 11, 2024 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 9.46 |
| Price / book | 8.74 |
| Price / cash | 8.75 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 8.58 |
| Quick Ratio | 7.67 |
| Current Ratio | 8.05 |
| Debt / equity | 0.18 |
| Long-term debt / equity | 0.17 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -1.95 |
|---|---|
| Earnings next year | -1.76 |
| Earnings next quarter | -0.50 |
| Earnings this year | -42.14% |
| Earnings next year | 15.42% |
| Earnings growth, 5 years | 0.15% |
| Past earnings growth | -10.19% - |
| Past sales growth | 50.90% - |
| Earnings vs last year | -34.52% |
| Sales vs last year | 31.28% |
| Earnings vs last quarter | -51.61% |
| Sales vs last quarter | 29.89% |
| Earnings | Nov 03 AMC |
| Surprise | -7.84% 0.56% |
Ownership
| Insiders own | 33.38% |
|---|---|
| Insider trades | -3.93% |
| Institutions own | 66.34% |
| Institution trades | 3.48% |
| Return on assets | -41.52% |
| Return on equity | -52.47% |
| Return on capital | -53.55% |
| Gross Margin | 89.26% |
| Operating margin | -69.79% |
| Profit Margin | -67.96% |
| 20-day average | -2.34% |
| 50-day average | 3.70% |
| 200-day average | 25.82% |
Technical
| Shares out | 38.82M |
|---|---|
| Shares floating | 25.87M |
| Short / float | 7.56% |
| Short ratio | 4.39 |
| Short interest | 1.96M |
| 52-week high | 28.89 -8.4% |
| 52-week low | 12.36 +114.2% |
| Volatility | 4.64% 6.60% |
| Average range | 1.46 |
| Strength index | 49.86 |
| Market sensitivity | 0.86 |
| Relative volume | 0.00 |
| Avg Volume | 445.41K |
| Volume | 28 |
Performance
| Perf Week | -0.44% |
|---|---|
| Perf Month | -4.22% |
| Perf Quarter | 8.50% |
| Perf Half Y | 62.42% |
| Perf YTD | 20.72% |
| Perf Year | 111.96% |
| Perf 3Y | - |
| Perf 5Y | - |
| Perf 10Y | - |
| Recommendation | 1.00 |
| Target Price | 31.57 |
| Prev Close | 26.35 |
| Price | 26.47 |
| Change % | 0.47% |
Analyst ratings
latest 8 of 8| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Oct 21, 2025 | Initiated | Raymond James | Strong Buy | $19 | -28.2% |
| Jun 24, 2025 | Initiated | BTIG Research | Buy | $30 | +13.3% |
| Apr 04, 2025 | Initiated | Ladenburg Thalmann | Buy | $32 | +20.9% |
| Nov 05, 2024 | Initiated | William Blair | Outperform | ||
| Nov 05, 2024 | Initiated | TD Cowen | Buy | $31 | +17.1% |
| Nov 05, 2024 | Initiated | JP Morgan | Overweight | $32 | +20.9% |
| Nov 05, 2024 | Initiated | Canaccord Genuity | Buy | $30 | +13.3% |
| Nov 05, 2024 | Initiated | BofA Securities | Buy | $32 | +20.9% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| NPCE | NeuroPace Inc | 243.02M |
| NMTC | NeuroOne Medical Technologies Corp | 6.81M |
| IRTC | iRhythm Holdings Inc | 3.12B |
| BFLY | Butterfly Network Inc | 1.81B |
| LIVN | LivaNova PLC | 4.97B |
| PHG | Koninklijke Philips NV ADR | 29.59B |
| BWAY | Brainsway Ltd ADR | 402.50M |
| MDT | Medtronic Plc | 129.81B |
| ECOR | ElectroCore Inc | 48.81M |
| AIFF | Firefly Neuroscience Inc | 15.24M |
Insider trading
latest 14 of 100| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| BURKE WILLIAM W | Director | Nov 12 '26 | Proposed Sale | 26.63 | 18,000 | 479,416 | Nov 12 04:09 PM | |
| Taylor Joseph Michael | Director | Nov 09 '26 | Sale | 27.22 | 10,200 | 277,644 | 38,278 | Nov 10 04:26 PM |
| Taylor Joseph Michael | Director | Nov 09 '26 | Proposed Sale | 26.75 | 10,200 | 272,850 | Nov 09 10:23 AM | |
| Woo Raymond | Chief Technology Officer | Nov 02 '26 | Option Exercise | 3.65 | 4,887 | 17,862 | 208,005 | Nov 04 12:22 PM |
| Woo Raymond | Chief Technology Officer | Nov 02 '26 | Sale | 26.96 | 4,887 | 131,754 | 203,118 | Nov 04 12:22 PM |
| Woo Raymond | Officer | Nov 02 '26 | Proposed Sale | 26.96 | 4,887 | 131,754 | Nov 02 11:13 AM | |
| Woo Raymond | Chief Technology Officer | Oct 01 '26 | Option Exercise | 3.65 | 4,887 | 17,862 | 208,005 | Oct 02 05:19 PM |
| Woo Raymond | Chief Technology Officer | Oct 01 '26 | Sale | 24.38 | 4,887 | 119,145 | 203,118 | Oct 02 05:19 PM |
| Woo Raymond | Officer | Oct 01 '26 | Proposed Sale | 24.38 | 4,887 | 119,145 | Oct 01 10:45 AM | |
| Chao Xingjuan | President and CEO | Sep 15 '26 | Sale | 25.03 | 20,846 | 521,775 | 746,345 | Sep 17 08:45 PM |
| Blumberg Scott | Chief Financial Officer | Sep 15 '26 | Option Exercise | 9.41 | 846 | 7,961 | 147,446 | Sep 17 08:40 PM |
| Blumberg Scott | Chief Financial Officer | Sep 15 '26 | Sale | 25.00 | 846 | 21,150 | 146,600 | Sep 17 08:40 PM |
| Blumberg Scott | Officer | Sep 15 '26 | Proposed Sale | 25.00 | 846 | 21,151 | Sep 15 04:36 PM | |
| Chao Xingjuan | Officer | Sep 15 '26 | Proposed Sale | 25.03 | 20,846 | 521,773 | Sep 15 04:29 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.25B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| VTWO | Vanguard Russell 2000 Index ETF | AUM: 16.90B |
| SCHA | Schwab U.S. Small-Cap ETF | AUM: 22.44B |
| IHI | iShares U.S. Medical Devices ETF | AUM: 4.08B |
| FFSM | Fidelity Fundamental Small-Mid Cap ETF | AUM: 1.59B |
| LFSC | F/m Emerald Life Sciences Innovation ETF | AUM: 128.79M |
| IWC | iShares Micro-Cap ETF | AUM: 1.23B |
News
latest 14 of 184- Ceribell Edges Estimates And Nudges Guidance Higher, But Slowing Growth And Wider Losses Test A Stock Priced Near Its Highs (Earnings Whispers)
- Ceribell Reports Third Quarter 2026 Financial Results (GlobeNewswire)
- Ceribell Expands Its Point-of-Care Brain Monitoring Platform with Commercial Launch of Delirium Monitoring Solution (GlobeNewswire)
- Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire)
- Ceribell Heads Into Q3 With Street Forecasts Still Below Its Raised Revenue Guidance (Earnings Whispers)
- Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026 (GlobeNewswire) +6.46%
- Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis (GlobeNewswire)
- CeriBell Inc (CBLL) (Q2 2026) Earnings Call Highlights: Revenue Accelerates 33% on Record ... (GuruFocus.com) +10.41%
- Ceribell Reports Second Quarter 2026 Financial Results (GlobeNewswire)
- Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review (GlobeNewswire)
- What To Expect From CeriBell Inc (CBLL) Q2 2026 Earnings (GuruFocus.com)
- CeriBell Inc (CBLL) Q2 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
- CeriBell Shares Gain After Medicare Approves Additional Payment for Delirium Monitoring System (InvestorsHub)
- Ceribell Secures CMS New Technology Add-On Payment (NTAP) for Breakthrough Point-of-Care Delirium Monitor System (GlobeNewswire)
Quarterly earnings
2026Q3 EPS -0.550 missed -0.510, from -0.370 a year earlier. Sales 29.34 beat 29.18, from 22.59 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-03 16:30 | -0.550 | -0.510 | -0.550 | 29.34 | 29.18 | EPS +7.8% · sales +0.6% | vs 2025Q3, year-ago quarter · EPS +48.6% · sales +29.9% | 8 | Open -22.00% vs SPY +1.15%. Close -3.11% vs SPY +1.65% |
| 2026Q2ended 2026-06-30 | 2026-08-10 16:30 | -0.510 | -0.471 | -0.507 | 28.10 | 27.28 | EPS +8.2% · sales +3.0% | vs 2025Q2, year-ago quarter · EPS +34.2% · sales +32.5% | 8 | Open +3.68% vs SPY +0.19%. Close +10.41% vs SPY -0.32% |
| 2026Q1ended 2026-03-31 | 2026-05-11 16:30 | -0.520 | -0.391 | -0.524 | 26.49 | 26.09 | EPS +33.1% · sales +1.6% | vs 2025Q1, year-ago quarter · EPS +44.4% · sales +29.3% | 8 | Open -7.58% vs SPY -0.33%. Close -16.50% vs SPY -0.15% |
| 2025Q4ended 2025-12-31 | 2026-02-24 16:30 | -0.360 | -0.412 | -0.363 | 24.78 | 23.93 | EPS -12.6% · sales +3.6% | vs 2024Q4, year-ago quarter · EPS -10.0% · sales +33.7% | 8 | Open -5.43% vs SPY +0.41%. Close -4.77% vs SPY +0.84% |
| 2025Q3ended 2025-09-30 | 2025-11-04 16:30 | -0.370 | -0.414 | -0.366 | 22.59 | 21.77 | EPS -10.7% · sales +3.8% | vs 2024Q3, year-ago quarter · EPS -80.0% · sales +31.4% | 8 | Open +3.02% vs SPY -0.04%. Close +7.88% vs SPY +0.35% |
| 2025Q2ended 2025-06-30 | 2025-08-05 16:30 | -0.380 | -0.397 | -0.376 | 21.20 | 20.45 | EPS -4.3% · sales +3.7% | vs 2024Q2, year-ago quarter · EPS +22.9% · sales +39.2% | 7 | Open -0.53% vs SPY +0.17%. Close -15.25% vs SPY +0.77% |
| 2025Q1ended 2025-03-31 | 2025-05-08 16:30 | -0.360 | -0.407 | -0.356 | 20.49 | 19.26 | EPS -11.6% · sales +6.4% | - | 6 | Open +4.04% vs SPY +0.25%. Close -6.61% vs SPY -0.13% |
| 2024Q4ended 2024-12-31 | 2025-02-25 16:30 | -0.400 | -0.318 | -0.351 | 18.53 | 17.55 | EPS +25.8% · sales +5.6% | - | 5 | Open -0.55% vs SPY +0.28%. Close -1.33% vs SPY +0.05% |
| 2024Q3ended 2024-09-30 | 2024-11-12 16:30 | -1.850 | -0.343 | -0.291 | 17.20 | 16.93 | EPS +438.7% · sales +1.6% | - | 4 EPS · 5 sales | Open +0.52% vs SPY +0.08%. Close -3.36% vs SPY +0.05% |
| 2024Q2ended 2024-06-30 | 2024-08-28 12:00 | -0.309 | - | -0.300 | 15.23 | - | EPS - · sales - | - | - | - |
| 2026Q4ended 2026-12-31 | - | - | -0.498 | - | - | 31.89 | EPS - · sales - | vs 2025Q4, year-ago quarter · EPS - · sales - | 8 | - |
| 2027Q1ended 2027-03-31 | - | - | -0.455 | - | - | 34.27 | EPS - · sales - | vs 2026Q1, year-ago quarter · EPS - · sales - | 6 | - |
| 2027Q2ended 2027-06-30 | - | - | -0.458 | - | - | 35.99 | EPS - · sales - | vs 2026Q2, year-ago quarter · EPS - · sales - | 6 | - |
| 2027Q3ended 2027-09-30 | - | - | -0.452 | - | - | 37.34 | EPS - · sales - | vs 2026Q3, year-ago quarter · EPS - · sales - | 6 | - |
| 2027Q4ended 2027-12-31 | - | - | -0.412 | - | - | 40.59 | EPS - · sales - | vs 2026Q4, year-ago quarter · EPS - · sales - | 5 | - |
| 2028Q1ended 2028-03-31 | - | - | -0.369 | - | - | 43.53 | EPS - · sales - | vs 2027Q1, year-ago quarter · EPS - · sales - | 4 | - |
Annual earnings
2025FY EPS -1.460 beat -1.507, from -3.390 a year earlier. Sales 89.06 beat 88.19, from 65.44 a year earlier
Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | -1.110 | - | - | 281.7 | - |
| 2029FYestimate | - | -1.150 | - | - | 230.6 | - |
| 2028FYestimate | - | -1.453 | - | - | 187.12 | - |
| 2027FYestimate | - | -1.755 | - | - | 147.71 | - |
| 2026FYestimate | - | -2.075 | - | - | 115.83 | - |
| 2025FY | -1.460 | -1.507 | -1.453 | 89.06 | 88.19 | - |
| 2024FY | -3.390 | -2.198 | -1.128 | 65.44 | 64.28 | - |
Quarterly results
2026Q3 revenue 29.34, from 22.59 a year earlier. Operating margin -70.0%, from -64.9% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E -2.08 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-04 | -2.08 | +5.1% |
| 2026Q4 | E | per share | 2026-11-04 | -0.50 | +13.1% |
| 2026FY | R | per share | 2026-11-04 | -2.07 | +4.2% |
| 2026Q4 | R | per share | 2026-11-04 | -0.50 | +11.3% |
| 2026Q4 | S | per share | 2026-11-04 | 31.89 | +0.6% |
| 2026FY | S | - | 2026-11-04 | 115.83 | +0.3% |
| 2026Q3 | E | per share | 2026-11-02 | -0.51 | -0.1% |
| 2026Q3 | R | per share | 2026-11-02 | -0.52 | -0.1% |
| 2026Q3 | S | per share | 2026-11-02 | 29.18 | +0.0% |
| 2026Q2 | E | per share | 2026-07-28 | -0.47 | 0.0% |
| 2026Q2 | R | per share | 2026-07-28 | -0.47 | 0.0% |
| 2026Q2 | S | per share | 2026-07-26 | 27.28 | 0.0% |
| 2026Q1 | E | per share | 2026-05-11 | -0.39 | 0.0% |
| 2026Q1 | R | per share | 2026-05-11 | -0.39 | 0.0% |
| 2026Q1 | S | per share | 2026-05-11 | 26.09 | 0.0% |
| 2025FY | E | per share | 2026-01-27 | -1.51 | +0.0% |
| 2025Q4 | E | per share | 2026-01-27 | -0.41 | +0.1% |
| 2025FY | S | per share | 2026-01-27 | 88.19 | +0.0% |
| 2025Q4 | S | per share | 2026-01-27 | 23.93 | 0.0% |
| 2025FY | R | per share | 2026-01-19 | -1.51 | 0.0% |
| 2025Q4 | R | per share | 2026-01-19 | -0.42 | 0.0% |
| 2025Q3 | E | per share | 2025-10-20 | -0.41 | 0.0% |
| 2025Q3 | R | per share | 2025-10-20 | -0.42 | 0.0% |
| 2025Q3 | S | per share | 2025-10-20 | 21.77 | 0.0% |
| 2025Q2 | E | per share | 2025-08-01 | -0.40 | +1.1% |
| 2025Q2 | R | per share | 2025-08-01 | -0.39 | -0.5% |
| 2025Q2 | S | per share | 2025-07-29 | 20.45 | -0.3% |
| 2025Q1 | E | per share | 2025-04-18 | -0.41 | -3.6% |
| 2025Q1 | S | per share | 2025-04-10 | 19.26 | +0.0% |
| 2025Q1 | R | per share | 2025-02-26 | -0.44 | +34.7% |
| 2024Q4 | R | per share | 2025-02-09 | -0.31 | +1.5% |
| 2024Q4 | E | per share | 2025-01-27 | -0.32 | 0.0% |
| 2024Q4 | S | per share | 2025-01-27 | 17.55 | 0.0% |
| 2024Q3 | E | per share | 2024-11-05 | -0.66 | +91.8% |
| 2024Q3 | R | per share | 2024-11-05 | -0.72 | +123.5% |
| 2024Q3 | S | per share | 2024-11-05 | 16.93 | -0.1% |
Estimate history
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|---|
| EPS per share | -1.093 | -0.866 | -1.128 | -1.462 | -1.9487 | - |
| Sales USD millions | 26 | 45 | 65 | 89 | 109 | - |
| Shares million shares | 34 | 34 | 36 | 37 | - | 39 |
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.291 | -0.351 | -0.356 | -0.376 | -0.366 | -0.363 | -0.524 | -0.507 | -0.555 |
| Sales USD millions | 17 | 19 | 20 | 21 | 23 | 25 | 26 | 28 | 29 |
| Shares million shares | 36 | 36 | 36 | 37 | 37 | 37 | 38 | 38 | 39 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 |
|---|---|---|---|---|---|
| Total Revenue | 108.72 | 89.06+36.1% | 65.44+44.7% | 45.23+74.5% | 25.92 |
| Cost of Goods Sold Incl. D&A | 11.67 | 10.79+24.2% | 8.69+23.1% | 7.06+59.4% | 4.43 |
| Gross Profit | 97.04 | 78.27+37.9% | 56.75+48.7% | 38.16+77.6% | 21.49 |
| Selling, General and Administrative Excl. Other | 172.91 | 136.68+41.7% | 96.46+41.4% | 68.20+18.6% | 57.51 |
| Research and Development | 25.37 | 19.14+41.2% | 13.56+50.8% | 8.99+24.2% | 7.24 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -75.87 | -58.40 | -39.71 | -30.04 | -36.02 |
| Interest Expense | 1.60 | 1.89-5.0% | 1.99-5.2% | 2.10+31.3% | 1.60 |
| Unusual Expense | 1.55 | 0.00-100.0% | 1.50 | -0.05-129.4% | 0.17 |
| Net Income Before Taxes | -73.88 | -53.41 | -40.45 | -29.45 | -37.16 |
| Income Taxes | 0.00 | 0.00 | 0.00-100.0% | 0.01 | 0.00 |
| Consolidated Net Income | -73.88 | -53.41 | -40.45 | -29.46 | -37.16 |
| Net Income From Continuing Operations | -73.88 | -53.41 | -40.45 | -29.46 | -37.16 |
| Net Income | -73.88 | -53.41 | -40.45 | -29.46 | -37.16 |
| EPS (Recurring) per share | -1.89 | -1.46 | -1.10 | -0.87 | -1.09 |
| EPS (Basic, Before Extraordinaries) per share | -1.95 | -1.46 | -1.13 | -0.87 | -1.09 |
| EPS (Diluted) per share | -1.95 | -1.46 | -1.13 | -0.87 | -1.09 |
| EBITDA | -74.85 | -57.06 | -38.57 | -29.19 | -35.52 |
| Non-Operating Income (Expense) | 5.14 | 6.88+151.1% | 2.74+3.8% | 2.64+312.5% | 0.64 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 21.08 | 12.22+125.9% | 5.41+155.2% | 2.12-66.1% | 6.26 |
| Price To Sales Ratio ratio | 8.64 | 9.00 | 14.18 | - | - |
| Gross Margin % | 89.26 | 87.89 | 86.72 | 84.38 | 82.91 |
| Operating Margin % | -69.79 | -65.57 | -60.68 | -66.43 | -138.96 |
| Net Margin % | -67.96 | -59.97 | -61.82 | -65.15 | -143.37 |
| Shares Outstanding million shares | 38.82 | 37.49+4.6% | 35.85+5.4% | 34.020.0% | 34.02 |
| Market Capitalization | 1,023.30 | 1,023.30+10.4% | 927.13+0.1% | 926.41 | - |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 29.34+29.9% | 28.10+32.5% | 26.49+29.3% | 24.78+33.7% | 22.59+31.3% | 21.20 | 20.49 | 18.53 |
| Cost of Goods Sold Incl. D&A | 3.00+13.2% | 2.16-14.3% | 3.37+35.9% | 3.14+36.5% | 2.65+21.6% | 2.52 | 2.48 | 2.30 |
| Gross Profit | 26.34+32.1% | 25.94+38.9% | 23.12+28.4% | 21.64+33.3% | 19.94+32.8% | 18.68 | 18.01 | 16.24 |
| Selling, General and Administrative Excl. Other | 46.89+35.6% | 45.92+36.5% | 43.87+36.2% | 36.24+24.5% | 34.59+38.6% | 33.63 | 32.21 | 29.12 |
| Research and Development | 7.40+48.6% | 6.75+39.2% | 6.16+44.9% | 5.06+29.4% | 4.98+46.5% | 4.85 | 4.25 | 3.91 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -20.55 | -19.98 | -20.75 | -14.60 | -14.65 | -14.95 | -14.21 | -12.88 |
| Interest Expense | 0.27-43.7% | 0.44-8.3% | 0.43-8.5% | 0.46-8.0% | 0.48-9.4% | 0.48 | 0.47 | 0.50 |
| Unusual Expense | 1.55 | 0.00 | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00 | 0.00 | 1.08 |
| Net Income Before Taxes | -21.35 | -19.27 | -19.74 | -13.53 | -13.46 | -13.64 | -12.78 | -12.58 |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Consolidated Net Income | -21.35 | -19.27 | -19.74 | -13.53 | -13.46 | -13.64 | -12.78 | -12.58 |
| Net Income From Continuing Operations | -21.35 | -19.27 | -19.74 | -13.53 | -13.46 | -13.64 | -12.78 | -12.58 |
| Net Income | -21.35 | -19.27 | -19.74 | -13.53 | -13.46 | -13.64 | -12.78 | -12.58 |
| EPS (Recurring) per share | -0.53 | -0.51 | -0.52 | -0.36 | -0.37 | -0.38 | -0.36 | -0.33 |
| EPS (Basic, Before Extraordinaries) per share | -0.55 | -0.51 | -0.52 | -0.36 | -0.37 | -0.38 | -0.36 | -0.35 |
| EPS (Diluted) per share | -0.55 | -0.51 | -0.52 | -0.36 | -0.37 | -0.38 | -0.36 | -0.35 |
| EBITDA | -20.30 | -19.74 | -20.51 | -14.30 | -14.26 | -14.63 | -13.87 | -12.52 |
| Non-Operating Income (Expense) | 1.01-39.2% | 1.15-35.8% | 1.44-24.2% | 1.53-19.0% | 1.66+654.5% | 1.79 | 1.90 | 1.89 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 7.10+125.4% | 6.00+89.3% | 3.72+101.1% | 4.26+93.6% | 3.15+128.3% | 3.17 | 1.85 | 2.20 |
| Price To Sales Ratio ratio | 8.64 | 7.25 | 7.26 | 9.16 | 5.11 | 8.78 | - | - |
| Gross Margin % | 89.77 | 92.32 | 87.27 | 87.33 | 88.28 | 88.13 | 87.88 | 87.61 |
| Operating Margin % | -70.03 | -71.11 | -78.30 | -58.89 | -64.84 | -70.53 | -69.33 | -69.52 |
| Net Margin % | -72.77 | -68.58 | -74.50 | -54.58 | -59.61 | -64.36 | -62.35 | -67.85 |
| Shares Outstanding million shares | 38.82+4.8% | 38.22+4.4% | 37.86+5.5% | 37.49+4.6% | 37.05+3.4% | 36.60 | 35.90 | 35.85 |
| Market Capitalization | 1,023.30+142.9% | 737.99+9.0% | 689.96+0.1% | 813.51-12.3% | 421.27-54.5% | 676.96 | 689.03 | 927.13 |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 |
|---|---|---|---|---|
| Cash & Short Term Investments | 159.26-18.1% | 194.37+463.6% | 34.49-49.5% | 68.23 |
| Short Term Receivables | 15.05+38.3% | 10.88+36.7% | 7.96+50.5% | 5.29 |
| Inventories | 7.29+5.0% | 6.94+18.2% | 5.87+43.9% | 4.08 |
| Other Current Assets | 2.91-10.5% | 3.25+52.6% | 2.13+82.1% | 1.17 |
| Total Current Assets | 184.51-14.4% | 215.44+327.0% | 50.45-36.0% | 78.77 |
| Net Property, Plant & Equipment | 4.33-2.7% | 4.45+19.0% | 3.74-3.4% | 3.87 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 0.81+72.3% | 0.47-2.1% | 0.48-2.0% | 0.49 |
| Other Assets | 6.16+21.5% | 5.07+19.3% | 4.25+27.6% | 3.33 |
| Total Assets | 195.80-13.1% | 225.41+282.6% | 58.92-31.9% | 86.46 |
| Short Term Debt Incl. Current Port. of LT Debt | 1.10+0.9% | 1.09-91.3% | 12.53+300.3% | 3.13 |
| Accounts Payable | 2.84+149.1% | 1.14+56.2% | 0.73+73.8% | 0.42 |
| Other Current Liabilities | 15.25+41.7% | 10.76+29.0% | 8.34+32.2% | 6.31 |
| Total Current Liabilities | 19.19+47.7% | 12.99-39.9% | 21.60+119.1% | 9.86 |
| Long Term Debt | 21.17+1.4% | 20.87+1142.3% | 1.68-88.9% | 15.09 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.11-71.8% | 0.39-18.7% | 0.48-2.0% | 0.49 |
| Total Liabilities | 40.47+18.2% | 34.25+44.1% | 23.76-6.6% | 25.44 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00-100.0% | 147.410.0% | 147.41 |
| Common Equity | 155.34-18.7% | 191.16 | -112.25 | -86.40 |
| Total Shareholders Equity | 155.34-18.7% | 191.16+443.7% | 35.16-42.4% | 61.01 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 155.34-18.7% | 191.16+443.7% | 35.16-42.4% | 61.01 |
| Total Liabilities & Stockholders Equity | 195.80-13.1% | 225.41+282.6% | 58.92-31.9% | 86.46 |
| Book Value Per Share per share | 4.14-22.3% | 5.33 | -3.30 | -2.54 |
| Tangible Book Value Per Share per share | 4.12-22.6% | 5.32 | -3.31 | -2.55 |
| Full-Time Employees people | 327+16.4% | 281+22.7% | 229 | - |
| Price to Book Ratio ratio | 8.70 | -6.82 | -6.81 | - |
| Return on Assets % | -25.36 | -28.46 | -40.53 | - |
| Return on Equity % | -30.83 | -35.75 | -61.27 | - |
| Return on Invested Capital % | -30.26 | -19.08 | -79.98 | -48.83 |
| Quick Ratio ratio | 9.24 | 16.05 | 2.06 | 7.57 |
| Current Ratio ratio | 9.61 | 16.59 | 2.34 | 7.99 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 | 2022FY12/31/2022 |
|---|---|---|---|---|---|
| Net Income | -73.88 | -53.41 | -40.45 | -29.46 | -37.16 |
| Depreciation | 1.02 | 1.34+17.5% | 1.14+34.1% | 0.85+70.0% | 0.50 |
| Other Funds (Non Cash) | 19.93 | 10.48+46.8% | 7.14+126.7% | 3.15-63.2% | 8.55 |
| Funds from Operations | -52.93 | -41.59 | -32.17 | -25.46 | -28.12 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -3.08 | 0.63 | -3.17 | -3.70 | -3.88 |
| Cash from Operating Activities | -56.01 | -40.96 | -35.35 | -29.16 | -32.00 |
| Capital Expenditures | -2.36 | -1.52 | -1.60 | -1.76 | -1.40 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 71.12 | -116.61 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | -110.38 | -210.81 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 181.50 | 94.20 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 68.77 | -118.14 | -1.60 | -1.76 | -1.40 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 7.68 | 5.44-97.1% | 188.91+20212.9% | 0.93-98.1% | 49.84 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | -0.31 |
| Sale of Common Pref Stock | 7.68 | 5.44-97.1% | 188.91+20212.9% | 0.93-98.1% | 50.15 |
| Proceedsfrom Stock Options | 0.00 | 0.00-100.0% | 187.79 | 0.00-100.0% | 50.00 |
| Issuance or Reduction of Debt, Net | -1.95 | 0.00 | 0.00 | -3.75 | -0.04 |
| Change in Long Term Debt | -1.95 | 0.00 | 0.00 | -3.75 | -0.04 |
| Issuance of Long Term Debt | 39.45 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -41.40 | 0.00 | 0.00 | -3.75 | -0.04 |
| Net Financing Active Other Cash Flow | -0.24 | -0.24-103.0% | 7.91 | 0.00 | 0.00 |
| Other Financing Activities Uses | -0.24 | -0.24 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 5.50 | 5.20-97.4% | 196.82 | -2.82-105.7% | 49.80 |
| Net Change in Cash | 18.25 | -153.89-196.3% | 159.88 | -33.74-305.7% | 16.40 |
| Free Cash Flow | -56.43 | -41.73 | -36.69 | -30.14 | -32.52 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 117.47-30.3% | 129.26-27.1% | 141.18-22.7% | 159.26-18.1% | 168.54+1094.5% | 177.43 | 182.70 | 194.37 |
| Short Term Receivables | 17.79+45.5% | 15.99+29.9% | 15.71+39.0% | 15.05+38.3% | 12.23+22.7% | 12.31 | 11.30 | 10.88 |
| Inventories | 6.96+15.6% | 6.74+12.3% | 6.90+5.3% | 7.29+5.0% | 6.02-12.9% | 6.00 | 6.55 | 6.94 |
| Other Current Assets | 2.99+4.5% | 3.66+81.2% | 2.88+1.1% | 2.91-10.5% | 2.86+26.0% | 2.02 | 2.85 | 3.25 |
| Total Current Assets | 145.21-23.4% | 155.65-21.3% | 166.68-18.1% | 184.51-14.4% | 189.66+470.2% | 197.76 | 203.40 | 215.44 |
| Net Property, Plant & Equipment | 3.29-4.9% | 3.54-5.9% | 3.97-1.2% | 4.33-2.7% | 3.46-25.3% | 3.76 | 4.02 | 4.45 |
| Total Investments and Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 1.14+67.6% | 1.03+83.9% | 0.96+81.1% | 0.81+72.3% | 0.68+44.7% | 0.56 | 0.53 | 0.47 |
| Other Assets | 6.73+17.7% | 6.12+9.1% | 6.47+17.2% | 6.16+21.5% | 5.72-34.3% | 5.61 | 5.52 | 5.07 |
| Total Assets | 156.37-21.6% | 166.35-19.9% | 178.08-16.6% | 195.80-13.1% | 199.53+324.0% | 207.69 | 213.47 | 225.41 |
| Short Term Debt Incl. Current Port. of LT Debt | 1.22+3.4% | 1.18+2.6% | 1.14+1.8% | 1.10+0.9% | 1.18+14.6% | 1.15 | 1.12 | 1.09 |
| Accounts Payable | 2.33+6.9% | 3.19+30.7% | 1.98+44.5% | 2.84+149.1% | 2.18-21.6% | 2.44 | 1.37 | 1.14 |
| Other Current Liabilities | 14.48+22.6% | 12.84+12.3% | 13.06+39.8% | 15.25+41.7% | 11.81+27.3% | 11.43 | 9.34 | 10.76 |
| Total Current Liabilities | 18.03+18.9% | 17.20+14.6% | 16.18+36.8% | 19.19+47.7% | 15.17+15.9% | 15.01 | 11.83 | 12.99 |
| Long Term Debt | 20.43+1.3% | 20.73+1.6% | 20.98+1.6% | 21.17+1.4% | 20.17-4.4% | 20.41 | 20.64 | 20.87 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.37+236.4% | 0.110.0% | 0.11-8.3% | 0.11-71.8% | 0.11-92.4% | 0.11 | 0.12 | 0.39 |
| Total Liabilities | 38.83+9.6% | 38.03+7.0% | 37.27+14.4% | 40.47+18.2% | 35.44-0.5% | 35.53 | 32.59 | 34.25 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 |
| Common Equity | 117.54-28.4% | 128.31-25.5% | 140.81-22.2% | 155.34-18.7% | 164.08 | 172.16 | 180.88 | 191.16 |
| Total Shareholders Equity | 117.54-28.4% | 128.31-25.5% | 140.81-22.2% | 155.34-18.7% | 164.08+1335.5% | 172.16 | 180.88 | 191.16 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Equity | 117.54-28.4% | 128.31-25.5% | 140.81-22.2% | 155.34-18.7% | 164.08+1335.5% | 172.16 | 180.88 | 191.16 |
| Total Liabilities & Stockholders Equity | 156.37-21.6% | 166.35-19.9% | 178.08-16.6% | 195.80-13.1% | 199.53+324.0% | 207.69 | 213.47 | 225.41 |
| Book Value Per Share per share | 3.03-31.6% | 3.36-28.5% | 3.72-26.2% | 4.14-22.3% | 4.43 | 4.70 | 5.04 | 5.33 |
| Tangible Book Value Per Share per share | 3.00-32.0% | 3.33-29.0% | 3.69-26.5% | 4.12-22.6% | 4.41 | 4.69 | 5.02 | 5.32 |
| Full-Time Employees people | - | - | - | 327+16.4% | - | - | - | 281 |
| Price to Book Ratio ratio | 8.70 | 5.23 | 4.42 | 4.95 | 2.44 | 3.72 | 3.60 | -6.82 |
| Return on Assets % | -41.52 | -35.29 | -30.84 | -25.36 | -42.55 | - | - | - |
| Return on Equity % | -52.47 | -43.93 | -37.53 | -30.83 | -59.78 | - | - | - |
| Return on Invested Capital % | -15.48 | -12.93 | -12.20 | -7.66 | -7.31 | -7.08 | -6.34 | -5.93 |
| Quick Ratio ratio | 7.67 | 8.66 | 9.87 | 9.24 | 12.11 | 12.77 | 16.64 | 16.05 |
| Current Ratio ratio | 8.05 | 9.05 | 10.30 | 9.61 | 12.50 | 13.17 | 17.19 | 16.59 |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q412/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -21.35 | -19.27 | -19.74 | -13.53 | -13.46 | -13.64 | -12.78 | -12.58 |
| Depreciation | 0.25-35.9% | 0.24-25.0% | 0.24-29.4% | 0.29-19.4% | 0.39 | 0.32 | 0.34 | 0.36 |
| Other Funds (Non Cash) | 8.43+249.8% | 5.47+95.4% | 3.19+31.3% | 2.84-8.1% | 2.41 | 2.80 | 2.43 | 3.09 |
| Funds from Operations | -12.67 | -13.55 | -16.31 | -10.39 | -10.67 | -10.52 | -10.01 | -9.12 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -0.40 | 0.69-76.9% | -2.98 | -0.38 | -0.58 | 2.99 | -1.39 | -1.16 |
| Cash from Operating Activities | -13.08 | -12.86 | -19.30 | -10.77 | -11.25 | -7.53 | -11.40 | -10.28 |
| Capital Expenditures | -0.76 | -0.22 | -0.83 | -0.55 | -0.46 | -0.23 | -0.28 | -0.49 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | 21.58 | -0.38 | 23.27 | 26.66 | -6.48 | -107.46 | -29.33 | 0.00 |
| Purchase of Investments | -12.72 | -48.88 | -26.73 | -22.04 | -45.98 | -113.46 | -29.33 | 0.00 |
| Sale Or Maturity of Investments | 34.30-13.2% | 48.50+708.3% | 50.00 | 48.70 | 39.50 | 6.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | 20.82 | -0.61 | 22.44 | 26.11 | -6.94 | -107.69 | -29.61 | -0.49 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 3.53+115.2% | 0.88-56.2% | 1.63+986.7% | 1.64-99.1% | 1.64 | 2.01 | 0.15 | 190.73 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 3.53+115.2% | 0.88-56.2% | 1.63+986.7% | 1.64-99.1% | 1.64 | 2.01 | 0.15 | 190.73 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.00 | 0.00 | 0.00 | 190.54 |
| Issuance or Reduction of Debt, Net | -1.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Long Term Debt | -1.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance of Long Term Debt | 39.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | -41.40 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Financing Active Other Cash Flow | 0.00 | 0.00 | 0.00 | -0.24 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | 0.00 | 0.00 | 0.00 | -0.24 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 1.58-11.7% | 0.88-56.2% | 1.63 | 1.40-99.3% | 1.79 | 2.01 | 0.00 | 191.03 |
| Net Change in Cash | 9.33 | -12.59 | 4.78 | 16.74-90.7% | -16.40 | -113.22 | -41.01 | 180.26 |
| Free Cash Flow | -13.18 | -12.88 | -19.42 | -10.95 | -11.62 | -7.60 | -11.55 | -10.64 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Product | 50.08 | 67.34 | +34.5% | 75.6% |
| Subscription | 15.37 | 21.73 | +41.4% | 24.4% |
| Total | 65.44 | 89.06 | +36.1% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| United States | 65.44 | 89.06 | +36.1% | 100.0% |
| Total | 65.44 | 89.06 | +36.1% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 7.56% | 2.0M | 25.9M | 431.01K |
| 2026-10-15 | 8.43% | 2.2M | 25.6M | 398.70K |
| 2026-09-30 | 7.89% | 2.0M | 25.6M | 379.99K |
| 2026-09-15 | 7.11% | 1.8M | 25.6M | 387.41K |
| 2026-08-31 | 7.46% | 1.9M | 25.6M | 384.12K |
| 2026-08-14 | 8.28% | 2.1M | 25.4M | 373.82K |
| 2026-07-31 | 8.17% | 2.0M | 24.7M | 357.54K |
| 2026-07-15 | 7.47% | 1.8M | 24.7M | 332.89K |
| 2026-06-30 | 7.99% | 2.0M | 24.7M | 320.18K |
| 2026-06-15 | 8.21% | 2.0M | 24.5M | 291.13K |
| 2026-05-29 | 7.86% | 1.9M | 24.5M | 296.22K |
| 2026-05-15 | 7.99% | 2.0M | 24.6M | 308.42K |
| 2026-04-30 | 7.74% | 1.9M | 24.4M | 291.23K |
| 2026-04-15 | 6.28% | 1.5M | 24.4M | 308.89K |
| 2026-03-31 | 7.82% | 1.9M | 24.0M | 335.37K |
| 2026-03-13 | 6.90% | 1.7M | 24.0M | 372.63K |
| 2026-02-27 | 8.01% | 1.9M | 24.0M | 430.44K |
| 2026-02-13 | 6.90% | 1.7M | 24.0M | 457.47K |
| 2026-01-30 | 7.26% | 1.6M | 22.4M | 461.45K |
| 2026-01-15 | 7.16% | 1.6M | 22.4M | 457.07K |
Option chain
Expiry 2026-11-20 · underlying 26.47, quoted 13 Nov 07:20 ET · ATM 25.00
Option quotes 11 Nov 09:35 ET. A date on a row is older than the last session (12 Nov). 16 rows.
Implied move 11.90% into expiry (call 1.925 + put 1.225 = 3.150 on 26.47)
Put/call open interest 0.12 (17 puts / 142 calls) · Put/call volume — no calls
IV change is points against the prior close.
| Type | Strike | Money | Bid | Ask | Last | Chg | IV | Open int | Volume | Last size | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| call 1 Jan | 12.50 | ITM | 12.10 | 16.00 | 0.00 | 0.00 | 670.1% +191.2 | 0 | 0 | 0 | 0.921 | -0.174 | 0.006 |
| put 4 Nov | OTM | 0.00 | 2.15 | 0.05 | 0.00 | 480.7% 0.0 | 8 | 0 | 0 | -0.077 | -0.171 | 0.006 | |
| call 1 Jan | 15.00 | ITM | 9.60 | 13.50 | 0.00 | 0.00 | 544.4% +160.8 | 0 | 0 | 0 | 0.901 | -0.166 | 0.007 |
| put 1 Jan | OTM | 0.00 | 2.15 | 0.00 | 0.00 | 386.5% 0.0 | 0 | 0 | 0 | -0.097 | -0.164 | 0.007 | |
| call 1 Jan | 17.50 | ITM | 7.20 | 11.00 | 0.00 | 0.00 | 439.7% +136.9 | 0 | 0 | 0 | 0.874 | -0.156 | 0.008 |
| put 1 Jan | OTM | 0.00 | 2.15 | 0.00 | 0.00 | 306.7% 0.0 | 0 | 0 | 0 | -0.122 | -0.154 | 0.008 | |
| call 1 Jan | 20.00 | ITM | 4.70 | 8.50 | 0.00 | 0.00 | 348.5% +117.2 | 0 | 0 | 0 | 0.838 | -0.141 | 0.009 |
| put 28 Oct | OTM | 0.00 | 0.90 | 0.30 | 0.00 | 236.2% 0.0 | 2 | 0 | 0 | -0.156 | -0.140 | 0.009 | |
| call 1 Jan | 22.50 | ITM | 2.20 | 6.00 | 0.00 | 0.00 | 265.2% -1.5 | 0 | 0 | 0 | 0.726 | -0.220 | 0.013 |
| put 25 Sep | OTM | 0.00 | 2.15 | 1.65 | 0.00 | 273.0% 0.0 | 2 | 0 | 0 | -0.263 | -0.220 | 0.013 | |
| call 6 Nov | 25.00 | ATM | 0.05 | 3.80 | 2.60 | 0.00 | 205.2% -1.1 | 37 | 0 | 0 | 0.629 | -0.194 | 0.015 |
| put 26 Oct | ATM | 0.00 | 2.45 | 0.73 | 0.00 | 199.8% -7.9 | 5 | 0 | 0 | -0.372 | -0.192 | 0.015 | |
| call 11 Nov | 30.00 | OTM | 0.00 | 0.60 | 0.30 | 0.00 | 63.7% 0.0 | 105 | 0 | 0 | 0.091 | -0.026 | 0.006 |
| put 1 Jan | ITM | 1.60 | 4.90 | 0.00 | 0.00 | 165.4% +101.7 | 0 | 0 | 0 | -0.909 | -0.023 | 0.006 | |
| call 1 Jan | 35.00 | OTM | 0.00 | 2.30 | 0.00 | 0.00 | 109.5% 0.0 | 0 | 0 | 0 | 0.057 | -0.031 | 0.005 |
| put 1 Jan | ITM | 6.60 | 10.30 | 0.00 | 0.00 | 272.1% +156.6 | 0 | 0 | 0 | -0.944 | -0.028 | 0.004 |
Latest SEC filings
30 of 308AllAll annual, quarterly, and current reportsInsider equity awards, transactions, and ownership (Section 16 Reports)Beneficial ownership reportsExempt offeringsRegistration statements and prospectusesFiling review correspondenceSEC orders and noticesProxy materialsTender offers and going private transactionsTrust indenture filings
10-Q filed 2026-11-03, period ended 2026-09-30. 10-K filed 2026-02-24, period ended 2025-12-31. CBLL on EDGAR
page 1 of 11Next →
| Filed | Form | Description | Period | Document |
|---|---|---|---|---|
| 2026-11-12 | 144 | no category | no report period | 0001959173-26-007977 index |
| 2026-11-10 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-11-09 · transaction | 0001193125-26-455553 index |
| 2026-11-09 | 144 | no category | no report period | 0001972359-26-000005 index |
| 2026-11-04 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-11-02 · transaction | 0001193125-26-446677 index |
| 2026-11-03 | 10-Q | All annual, quarterly, and current reports | 2026-09-30 | 0001193125-26-445555 index |
| 2026-11-03 | 8-K | All annual, quarterly, and current reports | 2026-11-03 | 0001193125-26-445487 index |
| 2026-11-02 | 144 | no category | no report period | 0001959173-26-007593 index |
| 2026-10-02 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-10-01 · transaction | 0001193125-26-412606 index |
| 2026-10-01 | 144 | no category | no report period | 0001959173-26-007171 index |
| 2026-09-17 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-15 · transaction | 0001193125-26-394799 index |
| 2026-09-17 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-15 · transaction | 0001193125-26-394789 index |
| 2026-09-15 | 144 | no category | no report period | 0001959173-26-006985 index |
| 2026-09-15 | 144 | no category | no report period | 0001959173-26-006983 index |
| 2026-09-10 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-08 · transaction | 0001193125-26-388299 index |
| 2026-09-10 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-08 · transaction | 0001193125-26-388295 index |
| 2026-09-08 | 144 | no category | no report period | 0001959173-26-006785 index |
| 2026-09-08 | 144 | no category | no report period | 0001959173-26-006771 index |
| 2026-09-04 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-02 · transaction | 0001193125-26-383893 index |
| 2026-09-04 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-09-02 · transaction | 0001193125-26-383891 index |
| 2026-09-02 | 144 | no category | no report period | 0001959173-26-006675 index |
| 2026-09-02 | 144 | no category | no report period | 0001959173-26-006672 index |
| 2026-08-25 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-21 · transaction | 0001193125-26-365558 index |
| 2026-08-25 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-21 · transaction | 0001193125-26-365554 index |
| 2026-08-25 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-21 · transaction | 0001193125-26-365552 index |
| 2026-08-25 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-21 · transaction | 0001193125-26-365550 index |
| 2026-08-25 | 4 | Insider equity awards, transactions, and ownership (Section 16 Reports) | 2026-08-21 · transaction | 0001193125-26-365546 index |
| 2026-08-24 | 144 | no category | no report period | 0001959173-26-006356 index |
| 2026-08-21 | 144 | no category | no report period | 0001959173-26-006355 index |
| 2026-08-21 | 144 | no category | no report period | 0001959173-26-006354 index |
| 2026-08-21 | 144 | no category | no report period | 0001959173-26-006353 index |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 409.40K | 2 |
| 2026-10 | 0 | 0 | 119.15K | 1 |
| 2026-09 | 0 | 0 | 1.88M | 6 |
| 2026-08 | 0 | 0 | 3.03M | 12 |
| 2026-07 | 0 | 0 | 776.10K | 1 |
| 2026-06 | 0 | 0 | 4.93M | 4 |
| 2026-05 | 0 | 0 | 1.24M | 8 |
| 2026-04 | 0 | 0 | 923.84K | 2 |
| 2026-03 | 0 | 0 | 924.06K | 4 |
| 2026-02 | 0 | 0 | 1.74M | 12 |
| 2026-01 | 0 | 0 | 2.67M | 5 |
| 2025-12 | 0 | 0 | 3.74M | 10 |
| 2025-11 | 0 | 0 | 892.96K | 2 |
Institutional holders
| Manager | % owned |
|---|---|
| FMR LLC | 16.48% |
| TPG GP A, LLC | 9.91% |
| Red Tree Management, LLC | 5.75% |
| BlackRock, Inc. | 5.10% |
| KCM Capital Inc | 3.00% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.98% |
| FEDERATED HERMES, INC. | 2.45% |
| FRANKLIN TEMPLETON INC | 2.40% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.37% |
| TimesSquare Capital Management, LLC | 2.04% |
Funds
| Fund | % owned |
|---|---|
| Fidelity Small Cap Growth Fund | 4.32% |
| Fidelity Stock Selector Small Cap Fund | 2.64% |
| Federated Hermes Kaufmann Small Cap Fund | 2.48% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 2.24% |
| Fidelity Small Cap Growth K6 Fund | 2.19% |
| Franklin Small Cap Growth Fund | 1.98% |
| Fidelity Series Small Cap Opportunities Fund | 1.94% |
| iShares Russell 2000 ETF | 1.88% |
| Select Medical Technology and Devices Portfolio | 1.11% |
| BNY Mellon Small/Mid Cap Growth Fund | 1.03% |
OakChart. CBLL. Cached 15 minutes. Terms